Focus
respiratory syncytial virus
Children Have Higher Hospitalizations From RSV Than Omicron or Influenza
A recent research paper found that hospitalization rates were over 80 percent for RSV and only 30 percent for omicron and the flu.
Pfizer Failed to Disclose Risks of Preterm Birth and Neonatal Death to Pregnant Women in RSV Vaccine Trial
A BMJ investigation revealed Pfizer was studying preterm births as an “adverse event of special interest” in RSV trial, but didn’t inform pregnant participants.
COVID-19 Is Less Frequent and Severe in Infants Than Other Respiratory Viruses, Study Finds
A study found infants under 2 months of age were less likely to experience SARS-CoV-2 infection and less severe illness compared with other respiratory viruses.
RSV Treatment for Infants in Limited Supply: CDC
The CDC has recommended prioritizing infants at the highest risk for severe RSV owing to the short supply of monoclonal antibody nirsevimab.
After Decades of Setbacks, First-Ever RSV Vaccine Approved: A Closer Look
The FDA approved the first-ever RSV vaccine for adults aged 60 and over—almost 60 years after the first RSV vaccine trial was called off due to two deaths.
